15 top-paid S&P 500 healthcare CEOs


The CEO of Regeneron was the top-paid CEO leading an S&P 500 healthcare company in 2020, according to a ranking from The Wall Street Journal.

For its CEO pay analysis, The Wall Street Journal used information from corporate proxy statements that S&P 500 companies filed through May for fiscal years ending after June 30, 2020. The data was collected by MyLogIQ. Pay data includes equity awards.

Here are the 15 healthcare CEOs with the highest pay on The Wall Street Journal's index for 2020.

1. Leonard Schleifer, MD, PhD, CEO of Regeneron: $135.4 million
2. Javier Rodriguez, CEO of Davita: $73.4 million
3. Samuel Hazen, CEO of Nashville, Tenn.-based HCA Healthcare: $30.4 million 
4. Alex Gorsky, CEO of Johnson & Johnson: $29.6 million
5. Marc Casper, CEO of Thermo Fisher Scientific: $26.4 million
6. Ari Bousbib, CEO of Iqvia: $25.6 million 
7. Michael Neidorff, CEO of Centene: $25 million
8. Richard Gonzalez, CEO of AbbVie: $24 million 
9. David Ricks, CEO of Eli Lilly: $23.7 million
10. Larry Merlo, CEO of CVS Health: $23 million
11. Kenneth Frazier, CEO of Merck: $22.1 million 
12. Albert Bourla, PhD, CEO of Pfizer: $21 million 
13. Robert Ford, CEO of Abbott Laboratories: $20.5 million
14. Giovanni Caforio, CEO of Bristol Myers Squibb: $20.2 million 
15. Robert Bradway, CEO of Amgen: $20.1 million

Read the full list here.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars